Netflix, Inc. (NFLX), Advanced Micro Devices, Inc. (AMD), Mylan Inc. (MYL): Today’s Three Best Stocks

Finally, branded- and generic-drug maker Mylan Inc. (NASDAQ:MYL) showed why one company’s pain — in this case, GlaxoSmithKline plc (ADR) (NYSE:GSK) — is another’s gain by advancing 4.8%. The reason for the move relates to the Food and Drug Administration’s release of a seven-page document yesterday outlining what tests would need to be conducted to bring a generic version of GlaxoSmithKline plc (ADR) (NYSE:GSK)’s blockbuster asthma treatment Advair to market. Advair’s patent expired three years ago, but no generics have emerged with the FDA failing to outline what tests a generic-drug maker would need to do to gain approval. With those guidelines now in place, Mylan Inc. (NASDAQ:MYL) is seen as a front-runner to have its generic to market within three or four years.

Mylan Inc. (NASDAQ:MYL) also enjoyed an upgrade today to “outperform” from “market perform” at research firm Bernstein, which also boosted its price target to $44 from $35 on the news. Generic-drugmakers have an endless sea of opportunities thanks to the finite length of time branded drugs stay on patent, which makes Mylan Inc. (NASDAQ:MYL) a name you should always be watching.

The article Today’s 3 Best Stocks originally appeared on Fool.com and is written by Sean Williams.

Fool contributor Sean Williams owns shares of Dell, but has no material interest in any other companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong. The Motley Fool owns shares of, and recommends Netflix.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.